<DOC>
	<DOCNO>NCT00316108</DOCNO>
	<brief_summary>The purpose study determine whether morbidity mortality high-risk surgical patient treat Carotid Wallstent conjunction FilterWire EX EZ System distal protection device less equal objective performance criterion ( OPC ) derive historic control undergo surgical intervention carotid endarterectomy ( CEA ) .</brief_summary>
	<brief_title>Boston Scientific Embolic Protection , Inc. ( EPI ) : A Carotid Stenting Trial High-Risk Surgical Patients ( BEACH )</brief_title>
	<detailed_description>Stroke third lead cause death country approximately 600,000 new stroke case year . Mortality rate high 40 percent report stroke result ischemia associate carotid distribution . Currently , primary therapy carotid artery occlusive disease carotid endarterectomy ( CEA ) surgical removal atheromatous material inside artery . Although CEA effective treatment majority patient carotid occlusive disease , remain need treatment option patient significant surgical risk factor . These patient show much high rate morbidity mortality . There approximately 50,000-70,000 patient year consider poor surgical candidate . These patient present either one anatomical co-morbid condition one-year stroke death rate 15 % traditional surgical treatment . Carotid artery stenting ( CAS ) report numerous single-center trial feasible treatment carotid artery stenosis . Moreover , risk benefit ratio suggest large patient high risk profile CEA treatment option . This trial study effect percutaneous intervention use Monorail™ Carotid Wallstent® Endoprosthesis ( Carotid Wallstent ) conjunction FilterWire System distal protection device ( FilterWire EX EZ ) rate common peri-procedural complication well long-term outcome compare historical outcome patient undergo CEA .</detailed_description>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Intracranial Arteriosclerosis</mesh_term>
	<criteria>Key General Patient must meet criterion either A B : A. Symptomatic : Carotid stenosis great equal 50 % via angiography associate cerebral retinal TIA ischemic stroke symptom within 180 day procedure , determine occurred cerebral hemisphere eye ipsilateral target carotid artery lesion reasonably attributable lesion ; B. Asymptomatic : Carotid stenosis great equal 80 % via angiography without associated cerebral retinal TIA ischemic stroke symptom within 180 day procedure . Target lesion native common carotid artery ( CCA ) , internal carotid artery ( ICA ) , carotid bifurcation . Target arterial segment stented diameter great equal 4.0 mm less equal 9.0 mm . Vessel diameter distal target lesion great equal 3.5 mm less equal 5.5 mm optimal `` land zone '' placement FilterWire EZ System visual angiographic recommendation describe instruction use ( IFU ) . Key HighRisk Eligibility Patients must qualify least one highrisk category . The highrisk category define : Anatomical condition [ one ( 1 ) criterion qualifies ] Comorbid condition Class I [ one ( 1 ) criterion qualifies ] Comorbid condition Class II [ two ( 2 ) criterion qualify ] Patient experience evolve , acute , recent stroke within 21 day study evaluation . A total occlusion ipsilateral carotid artery . ( Only RollIn Pivotal patient . ) A total occlusion contralateral carotid artery . ( Only Bilateral Registry patient . ) Preexisting stent ( ) : RollIn Pivotal Patients : locate within ipsilateral carotid distribution ; stent place contralateral vessel within previous 30 day study enrollment . Bilateral Registry Patients : locate within carotid distribution . A target lesion expect require one stent . Known cardiac source emboli type likely associate cerebral ischemic event [ e.g . endocarditis , intracardiac thrombus , embolicassociated cardiovascular lesion , current arrhythmia ( e.g . atrial fibrillation , atrial flutter , etc. ) ] . Myocardial infarction ( MI ) within 72 hour prior index procedure , define creatine kinase ( CK ) MB &gt; 2 X local laboratory 's upper limit normal ( ULN ) . Any surgery require general anesthesia ( e.g . coronary artery bypass graft [ CABG ] , valve replacement , abdominal aortic aneurysm ) less equal 30 day precede stent procedure . The patient enrol another investigational study protocol complete required followup period evaluation . The patient may participate another investigational study may confound treatment outcome BEACH protocol .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Carotid</keyword>
	<keyword>Carotid Artery Stenting</keyword>
	<keyword>Stent</keyword>
	<keyword>Carotid Endarterectomy</keyword>
	<keyword>Stroke</keyword>
	<keyword>Transient Ischemic Attack</keyword>
	<keyword>Stenosis</keyword>
	<keyword>Atherosclerotic Disease</keyword>
</DOC>